EZH2 and ovarian carcinoma: Özeş et al. (2018) demonstrated that PKA can phosphorylate EZH2, leading to mitochondrial dysfunction and the interaction of EZH2 with STAT3, ultimately inhibiting STAT3 phosphorylation and suppressing epithelial ovarian cancer cell growth (Özeş et al., 2018).